Hostname: page-component-7c8c6479df-995ml Total loading time: 0 Render date: 2024-03-29T00:55:15.041Z Has data issue: false hasContentIssue false

Factors Associated with Health-Related Quality of Life in Multiple Sclerosis

Published online by Cambridge University Press:  02 December 2014

Wilma M. Hopman
Affiliation:
Clinical Research Centre, Kingston General Hospital
Helen Coo
Affiliation:
Department of Community Health and Epidermiology, Queen's University, Kingston, Ontario, Canada
Cathy M. Edgar
Affiliation:
Multiple Sclerosis Clinic, Kingston General Hospital
Evelyn V. McBride
Affiliation:
Multiple Sclerosis Clinic, Kingston General Hospital
Andrew G. Day
Affiliation:
Clinical Research Centre, Kingston General Hospital
Donald G. Brunet
Affiliation:
Multiple Sclerosis Clinic, Kingston General Hospital
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Background:

Much research has gone into the assessment of function and health-related quality of life (HRQOL) in those with multiple sclerosis (MS). The Medical Outcomes Study 36-item short form (SF-36) has been widely used in this population but current recommendations are that it be supplemented with condition-specific measures such as the MS Quality of Life Inventory (MSQLI) and the MS Functional Composite (MSFC). The goal of the baseline component of this study was the measurement of generic and condition-specific HRQOL, and the identification of factors associated with these outcomes.

Methods:

HRQOL was assessed at the baseline phase of a longitudinal study. Participants completed the assessment during their regularly scheduled clinic visit.

Results:

300 of 387 eligible patients agreed to participate, for a response rate of 77.5%. Age ranged from 22 to 77 years, while duration of MS ranged from 1 to 47 years. Mean SF-36 scores were well below age- and sex-adjusted normative data. Only 240 completed the MSFC component. Higher EDSS, use of support services, pain medications, clinical depression and antidepressant use were associated with poorer HRQOL, while higher income and education were associated with better HRQOL.

Conclusions:

There is a substantial burden of illness associated with MS when compared to normative HRQOL data. This was more pronounced in physically- than in mentally-oriented domains. Assessment of HRQOL provides a valuable complement to the EDSS by providing information about the patient perception of function and HRQOL beyond that which can be obtained by physical assessment alone.

Résumé:

RÉSUMÉ:Contexte:

L'évaluation du fonctionnement et de la qualité de vie reliée à la santé (QVRS) chez les patients atteints de sclérose en plaques (SEP) a fait l'objet de beaucoup de recherches. Le Medical Outcomes Study 36-item short form (SF-36) a été très utilisé chez ces patients. Cependant, on recommande maintenant d'y ajouter des mesures spécifiques à la maladie comme le MS Quality of Life Inventory (MSQLI) et le MS Functional Composite (MSFC). Le but du volet initial de cette étude était de mesurer la QVRS générique et spécifique à la maladie et d'identifier les facteurs associés à ses répercussions.

Méthodes :

La QVRS a été évaluée lors de la phase initiale d'une étude longitudinale. Les participants complétaient l'évaluation pendant leur visite de suivi régulier à la clinique.

Résultats :

300 des 387 patients éligibles ont accepté de participer, soit un taux de participation de 77,5%. Ils étaient âgés de 22 à 77 ans et atteints de la maladie depuis 1 à 47 ans. Les scores SF-36 moyens étaient bien en deçà des données normatives ajustées pour l'âge et le sexe. Seulement 240 patients ont complété la composante MSFC. Un score EDSS plus élevé, l'utilisation de services de soutien, une médication anti-douleur, la dépression clinique et l'utilisation d'antidépresseurs étaient associés à une moins bonne QVRS. Un revenu et un niveau de scolarité plus élevés étaient associés à une meilleure QVRS.

Conclusions :

Il existe un fardeau dû00E0; la maladie qui est substantiel chez les patients atteints de la SEP par rapport aux données normatives sur la QVRS. Ce fardeau était plus lourd dans les domaines axés sur le fonctionnement physique que sur le fonctionnement mental. L'évaluation de la QVRS est un complément précieux au EDSS en fournissant de l'information sur la perception qu'a le patient de son état fonctionnel et de sa QVRS, au-delà de ce qui peut être obtenu par l'évaluation physique seule.

Type
Original Articles
Copyright
Copyright © The Canadian Journal of Neurological 2007

References

1. The Canadian Burden of Illness Study Group. Burden of illness in multiple sclerosis: Part I: Cost of illness. Can J Neuro Sci. 1998; 25:23-30.Google Scholar
2. Patwardhan, MB, Matchar, DB, Samsa, GP, McCrory, DC, Williams, RG, Li, TT. Cost of multiple sclerosis by level of disability: a review of literature. Mult Scler. 2005; 11:232-9.CrossRefGoogle ScholarPubMed
3. Grima, DT, Torrance, GW, Francis, G, Rice, G, Rosner, AJ, Lafortune, L. Cost and health-related quality of life consequences of multiple sclerosis. Mult Scler. 2000; 6:91-8.Google Scholar
4. The Canadian Burden of Illness Study Group. Burden of illness in multiple sclerosis: Part II: Quality of Life. Can J Neuro Sci. 1998; 25:31-38.Google Scholar
5. Brunet, DG, Hopman, WM, Singer, MA, Edgar, CM, MacKenzie, TA. Measurement of health-related quality of life in multiple sclerosis patients. Can J Neuro Sci. 1996; 23:99-103.CrossRefGoogle ScholarPubMed
6. Aronson, KJ. Quality of life among persons with multiple sclerosis and their caregivers. Neurology. 1997; 48:74-80.Google Scholar
7. Pittock, SJ, Mayr, WT, McClelland, RL, Jorgensen, NW, Weigand, SD, Noseworthy, JH, et al. Quality of life is favorable for most patients with multiple sclerosis: a population-based cohort study. Arch Neurol. 2004; 61:679-86.Google Scholar
8. Kurtzke, JF. Rating neurological impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology, 1988; 33:1444-52.Google Scholar
9. Patti, F, Cacopardo, M, Palermo, F, Ciancio, MR, Lopes, R, Restivo, D, et al. Health-related quality of life and depression in an Italian sample of multiple sclerosis patients. J Neurol Sci. 2003; 211:55-62.Google Scholar
10. Ware, JE Jr, Snow, KK, Kosinski, M. SF-36 health survey: manual & interpretation guide. Boston, Massachusetts: The Health Institute, New England Medical Center; 1993.Google Scholar
11. Ware, JE, Kosinski, M, Keller, SD. SF-36 physical and mental health summary scales: a user manual and interpretation guide. Boston MA Health Institute; 1994.Google Scholar
12. Singer, MA, Hopman, WM, MacKenzie, TA. Psychological adjustment in four chronic medical conditions. Qual Life Res. 1999; 8:687-91.Google Scholar
13. Ritvo, PG, Fischer, JS, Miller, DM, Andrews, H, Paty, DW, LaRocca, NG. Multiple sclerosis quality of life inventory: a user’s manual. New York: National Multiple Sclerosis Society; 1997.Google Scholar
14. Hopman, WM, Coo, H, Brunet, DG, Edgar, CM, Singer, MA. Longitudinal assessment of health-related quality of life (HRQOL) of patients with multiple sclerosis. International J MS Care. 2000; 2:15-26.Google Scholar
15. Vickrey, BG, Hays, RD, Genovese, BJ, Myers, LW, Ellison, GW. Comparison of a generic to disease-targeted health-related quality-of-life measure for multiple sclerosis. J Clin Epid. 1997; 50:557-69.CrossRefGoogle ScholarPubMed
16. Miller, DM, Rudick, RA, Cutter, G, Baier, M, Fischer, JS. Clinical significance of the multiple sclerosis functional composite: relationship to patient-reported quality of life. Arch Neurol. 2000; 57:1319-24.CrossRefGoogle ScholarPubMed
17. Sullivan, JJL, Edgeley, K, Dehoux, E. A survey of multiple sclerosis. Part 1: perceived cognitive problems and compensatory strategy use . Can J Rehab. 1990; 4:99-105.Google Scholar
18. Fischer, JS, Rudick, RA, Cutter, GR, Reingold, SC. The Multiple Sclerosis Functional Composite measure (MSFC): an integrated approach to MS clinical outcome assessment. Mult Scler. 1999; 5:244-50.Google Scholar
19. Coo, H, Hopman, WM, Edgar, CM, McBride, EV, Brunet, DG. The paced auditory serial addition test: to what extent is it performed as instructed, and is it associated with disease course? Mult Scler. 2005; 11:85-9.Google Scholar
20. Fischer, JS, Jak, AJ, Knicker, JE, Rudick, RA, Cutter, G. Administration and scoring manual for the Multiple Sclerosis Functional Composite Measure. New York, New York: National Multiple Sclerosis Society; Revised 2001.Google Scholar
21. Hopman, WM, Towheed, T, Anastassiades, T, Tenenhouse, A, Poliquin, S, Berger, C, et al. Canadian normative data for the SF-36 health survey. CMAJ. 2000; 163:265-71.Google Scholar
22. Janardhan, V, Nakshi, R. Quality of life in patients with multiple sclerosis: the impact of fatigue and depression. J Neurol Sci. 2002; 15:51-8.Google Scholar
23. Lobentanz, IS, Asenbaum, S, Vass, K, Sauter, C, Klosch, G, Kollegger, H, et al. Factors influencing quality of life in multiple sclerosis patients: disability, depressive mood, fatigue and sleep quality. Acta Neurol Scand. 2004; 110:6-13.Google Scholar
24. McCabew, MP, De Judicibus, M. The effects of economic disadvantage on psychological well-being and quality of life among people with multiple sclerosis. J Health Psyc. 2005; 10:163-73.Google Scholar
25. Williams, RM, Turner, AP, Hatzakis, M Jr, Bowen, JD, Rodriques, AA, Hasselkorn, JK. Prevalence and correlates of depression among veterans with multiple sclerosis. Neurology. 2005; 64:75-80.Google Scholar
26. Jiang, Y, Hesser, JE. Associations between health-related quality of life and demographics and health risks. Results from Rhode Island’s 2002 Behavioural Risk Factor Survey. Health Qual Life Outcomes. 2006; 3:14 (Epub ahead of print).Google Scholar
27. Miller, A, Dishon, S. Health-related quality of life in Multiple Sclerosis: the impact of disability, gender and employment status. Qual Life Res. 2006; 15:259-71.Google Scholar